Research on Mylan Inc. and Watson Pharmaceuticals Inc. - Generic Drug Makers Take to the Courts
(firmenpresse) - JOHANNESBURG, SOUTH AFRICA -- (Marketwire) -- 04/12/12 -- offers investors comprehensive research on the Drugs - Generic industry and has completed analytical research on (NASDAQ: MYL) (NYSE: WPI). Register with us today at to have free access to these researches.
A series of legal battles could shape both the short- and long-term for generic drug makers, as battles over exclusivity rights and patent claims could send companies in different directions.
is an online platform where investors doing their due-diligence on the Drugs - Generic industry can have easy and free access to our analyst research and opinions on Mylan Inc. and Watson Pharmaceuticals Inc.; investors and shareholders of these companies can simply register for a complimentary membership at .
One company that has been working hard as of late is Watson Pharmaceuticals Inc. The company has an Abbreviated New Drug Application for a generic version of Sanctura XR. The drug is currently pending with the FDA but could send revenues higher if approved, considering the impressive U.S. sales of the drug in the past year. Investors can register for free to access the research reports on at .
Exclusivity rights have also been a point of contention for generic drug makers. Mylan Inc. is suing the FDA to reverse a decision that granted 180 days of exclusivity to rival Teva Pharmaceuticals for the generic type of drug Provigil. Mylan is pushing for a quick decision and hopes to market the drug shortly after. The case will be well worth tracking for Mylan investors. Investors can register for free to access the research reports on at .
Register now at to have free access to our reports on the Drugs - Generic industry.
StockCall.com is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines.
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 12.04.2012 - 06:15 Uhr
Sprache: Deutsch
News-ID 1102272
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
JOHANNESBURG, SOUTH AFRICA
Phone:
Kategorie:
Investment Services & Trading
Anmerkungen:
Diese Pressemitteilung wurde bisher 94 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Research on Mylan Inc. and Watson Pharmaceuticals Inc. - Generic Drug Makers Take to the Courts
"
steht unter der journalistisch-redaktionellen Verantwortung von
StockCall (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
